Common Contracts

Execution Version OPTION AND LICENSE AGREEMENT

Option and License Agreement • May 5th, 2020 • New York

• Contract Type
  Option and License Agreement
• Filed
  May 5th, 2020
• Jurisdiction
  New York

This Option and License Agreement is made as of March 21, 2016 (the “Execution Date”) by and between Aptose Biosciences Inc., a Canadian corporation having a place of business at 5955 Airport Road, Suite 228, Mississauga, Ontario, L4V 1R9, Canada (“Aptose”) and CrystalGenomics, Inc., a South Korean corporation having a place of business at 5th F. Bldg. A, Korea Bio Park, 700 Daewangpangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 463-400 Korea (“CG”). Aptose and CG are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.

EXPLANATORY NOTE: [*] INDICATES THE PORTION OF THIS EXHIBIT THAT HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IN PUBLICLY DISCLOSED.

Option and License Agreement • April 22nd, 2019 • Aptose Biosciences Inc. • Biological products, (no disgnostic substances) • New York

• Contract Type
  Option and License Agreement
• Filed
  April 22nd, 2019
• Company
  Aptose Biosciences Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

This Option and License Agreement is made as of March 21, 2016 (the “Execution Date”) by and between Aptose Biosciences Inc., a Canadian corporation having a place of business at 5955 Airport Road, Suite 228, Mississauga, Ontario, L4V 1R9, Canada (“Aptose”) and CrystalGenomics, Inc., a South Korean corporation having a place of business at 5th F. Bldg. A, Korea Bio Park, 700 Daewangpangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 463-400 Korea (“CG”). Aptose and CG are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.

OPTION AND LICENSE AGREEMENT

Option and License Agreement • June 8th, 2016 • Aptose Biosciences Inc. • Biological products, (no disgnostic substances) • New York

• Contract Type
  Option and License Agreement
• Filed
  June 8th, 2016
• Company
  Aptose Biosciences Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

This Option and License Agreement is made as of March 21, 2016 (the “Execution Date”) by and between Aptose Biosciences Inc., a Canadian corporation having a place of business at 5955 Airport Road, Suite 228, Mississauga, Ontario, L4V 1R9, Canada (“Aptose”) and CrystalGenomics, Inc., a South Korean corporation having a place of business at 5th F. Bldg. A, Korea Bio Park, 700 Daewangpangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 463-400 Korea (“CG”). Aptose and CG are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.